AC
Amia Capital Portfolio holdings
AUM
$32.1M
This Quarter Return
-4.57%
1 Year Return
-3.89%
3 Year Return
+25.64%
5 Year Return
–
10 Year Return
–
AUM
$86.1M
AUM Growth
+$86.1M
(-29%)
Cap. Flow
-$29.9M
Cap. Flow
% of AUM
-34.8%
Top 10 Holdings %
Top 10 Hldgs %
85.07%
Holding
39
New
1
Increased
10
Reduced
24
Closed
3
Top Buys
| 1 |
Vale
VALE
|
$5.82M |
| 2 |
Petrobras
PBR
|
$1.78M |
| 3 |
MTEM
Molecular Templates, Inc.
MTEM
|
$205K |
| 4 |
Fate Therapeutics
FATE
|
$135K |
| 5 |
Black Diamond Therapeutics
BDTX
|
$81.6K |
Top Sells
Sector Composition
| 1 | Healthcare | 47.91% |
| 2 | Materials | 11.06% |
| 3 | Energy | 10.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Grifois
GRFS
$6.59B
| $22.5M | 26.12% |
1,295,478
-281,819
| -18% | -$4.89M |
|
|
LSXMK
2
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $12.2M | 14.14% |
367,779
-193,908
| -35% | -$6.41M |
|
|
LSXMA
3
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $11.7M | 13.64% |
353,877
-192,742
| -35% | -$6.39M |
|
|
4
Vale
VALE
$43.4B
| $9.52M | 11.06% |
900,000
+550,000
| +157% | +$5.82M |
|
|
5
Petrobras
PBR
$80B
| $9.26M | 10.76% |
1,300,000
+250,000
| +24% | +$1.78M |
|
6
Ionis Pharmaceuticals
IONS
$9.16B
| $2.02M | 2.35% |
42,552
-2,647
| -6% | -$126K |
|
|
BBL
7
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
| $1.7M | 1.98% |
39,933
-387,763
| -91% | -$16.5M |
|
8
Neurocrine Biosciences
NBIX
$14.1B
| $1.53M | 1.78% |
15,939
-2,360
| -13% | -$227K |
|
9
Incyte
INCY
$16.8B
| $1.43M | 1.66% |
15,939
-3,853
| -19% | -$346K |
|
10
Vertex Pharmaceuticals
VRTX
$103B
| $1.37M | 1.59% |
5,026
-2,325
| -32% | -$633K |
|
11
argenx
ARGX
$43.2B
| $1.33M | 1.55% |
5,077
-239
| -4% | -$62.8K |
|
12
Moderna
MRNA
$9.41B
| $1.25M | 1.45% |
17,607
-4,441
| -20% | -$314K |
|
13
Alnylam Pharmaceuticals
ALNY
$58.6B
| $1.01M | 1.17% |
6,937
-2,467
| -26% | -$359K |
|
14
Halozyme
HALO
$8.58B
| $953K | 1.11% |
36,279
-9,655
| -21% | -$254K |
|
|
MYOK
15
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $878K | 1.02% |
6,437
-672
| -9% | -$91.7K |
|
|
ALXN
16
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $808K | 0.94% |
7,061
-386
| -5% | -$44.2K |
|
17
Agios Pharmaceuticals
AGIO
$2.28B
| $761K | 0.88% |
21,740
-356
| -2% | -$12.5K |
|
18
Esperion Therapeutics
ESPR
$468M
| $761K | 0.88% |
20,464
-439
| -2% | -$16.3K |
|
19
MacroGenics
MGNX
$110M
| $608K | 0.71% |
24,131
-1,272
| -5% | -$32K |
|
|
ITCI
20
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $512K | 0.59% |
19,972
-5,630
| -22% | -$144K |
|
|
SAGE
21
DELISTED
Sage Therapeutics
SAGE
| $467K | 0.54% |
7,644
+447
| +6% | +$27.3K |
|
|
RDUS
22
DELISTED
Radius Health, Inc.
RDUS
| $440K | 0.51% |
38,841
+290
| +0.8% | +$3.29K |
|
|
23
Fate Therapeutics
FATE
$119M
| $408K | 0.47% |
10,209
+3,371
| +49% | +$135K |
|
24
Exelixis
EXEL
$10B
| $378K | 0.44% |
15,479
-464
| -3% | -$11.3K |
|
25
CRISPR Therapeutics
CRSP
$4.79B
| $366K | 0.43% |
4,374
+272
| +7% | +$22.8K |
|